These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30408836)

  • 21. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing.
    Vikingsson S; Krauss ST; Winecker RE; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Aug; 46(7):697-704. PubMed ID: 35639619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilution of Urine Followed by Adulteration in an Attempt to Deceive the Laboratory.
    Feldhammer M; Saitman A; Nguyen L; Milstid B
    J Anal Toxicol; 2019 Jan; 43(1):e7-e9. PubMed ID: 30192938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrite adulteration of workplace urine drug-testing specimens. I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration.
    Urry FM; Komaromy-Hiller G; Staley B; Crockett DK; Kushnir M; Nelson G; Struempler RE
    J Anal Toxicol; 1998; 22(2):89-95. PubMed ID: 9547404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Nitro-6-monoacetylmorphine: potential marker for monitoring the presence of 6-monoacetylmorphine in urine adulterated with potassium nitrite.
    Luong S; Shimmon R; Hook J; Fu S
    Anal Bioanal Chem; 2012 Jun; 403(7):2057-63. PubMed ID: 22526670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 28. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adulterants causing false negatives in illicit drug testing.
    Mikkelsen SL; Ash KO
    Clin Chem; 1988 Nov; 34(11):2333-6. PubMed ID: 3052928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous determination of creatinine and uric acid in urine by liquid chromatography-tandem mass spectrometry with polarity switching electrospray ionization.
    Kwon W; Kim JY; Suh S; In MK
    Forensic Sci Int; 2012 Sep; 221(1-3):57-64. PubMed ID: 22503624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrity of Urine Specimens for Toxicological Analysis - Adulteration, Mechanisms of Action, and Laboratory Detection.
    Wu AH
    Forensic Sci Rev; 1998 Jun; 10(1):47-65. PubMed ID: 26255660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The measurement of nitrite in adulterated urine samples by high-performance ion chromatography.
    Singh J; Elberling JA; Hemphill DG; Holmstrom J
    J Anal Toxicol; 1999; 23(3):137-40. PubMed ID: 10369320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating Novel Markers for Specimen Validity Testing.
    Kyle PB; Kaur J
    Arch Pathol Lab Med; 2020 Feb; 144(2):168-171. PubMed ID: 31755779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry.
    Melikian AA; O'Connor R; Prahalad AK; Hu P; Li H; Kagan M; Thompson S
    Carcinogenesis; 1999 Apr; 20(4):719-26. PubMed ID: 10223205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening.
    Pelander A; Tyrkkö E; Ojanperä I
    Rapid Commun Mass Spectrom; 2009 Feb; 23(4):506-14. PubMed ID: 19142846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatinine in urine - a method comparison.
    Luginbühl M; Weinmann W
    Drug Test Anal; 2017 Oct; 9(10):1537-1541. PubMed ID: 28102586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.